Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  28 (2024)
Volume  27 (2023)
Volume  26 (2022)
Volume  25 (2021)
Volume  24 (2020)
Volume  23 (2019)
Volume  22 (2018)
Volume  21 (2017)
Volume  20 (2016)
Volume  19 (2015)
Volume  18 (2014)
Volume  17 (2013)
Volume  16 (2012)
Volume  15 (2011)
Volume  14 (2010)
Volume  13 (2009)
Volume  12 (2008)
Volume  11 (2007)
Volume  10 (2006)
Volume  9 (2005)
Volume  8 (2004)
Related articles

VOLUME 22 , ISSUE 8 ( 2018 ) > List of Articles

ORIGINAL ARTICLE

The platelet count and its implications in sickle cell disease patients admitted for intensive care

Durjoy K. Shome, Ahmed Jaradat, Ahmed I. Mahozi, Ali S. Sinan, Ali Ebrahim, Mohammed Alrahim, Mohammad S. Ebraheem, Eman J. Mansoor, Kameela S. Majed, Sheikh A. Azeez Pasha

Keywords : Acute physiology, chronic health evaluation II, multi-organ dysfunction score, platelets, sickle cell disease, thrombocytopenia

Citation Information : Shome DK, Jaradat A, Mahozi AI, Sinan AS, Ebrahim A, Alrahim M, Ebraheem MS, Mansoor EJ, Majed KS, Azeez Pasha SA. The platelet count and its implications in sickle cell disease patients admitted for intensive care. Indian J Crit Care Med 2018; 22 (8):585-590.

DOI: 10.4103/ijccm.IJCCM_49_18

License: CC BY-ND 3.0

Published Online: 01-09-2018

Copyright Statement:  Copyright © 2018; The Author(s).


Abstract

Background and Aims: In sickle cell disease (SCD) patients admitted for intensive care, evaluation of platelet counts in different types of sickle cell complications and its prognostic relevance are not well-studied. Illuminating these aspects were the objectives of this study. Materials and Methods: A chart review of 136 adult SCD patients consecutively admitted to our Intensive Care Unit (ICU) was done. The prognosis on day 1 was assessed by Acute Physiology and Chronic Health Evaluation (APACHE II) and multiple organ dysfunction scores (MODS). Receiver operating characteristic (ROC) curves evaluated the ability of platelet counts, MODS, and APACHE II scores to predict survival. Results: The most common types of crises were severe pain (n = 53), acute chest syndrome (n = 40), and infection (n = 18); 17 patients were nonsurvivors. Platelet counts varied widely (range, 19–838 × 109/L) with thrombocytopenia (n = 30) and thrombocytosis (n = 11). Counts correlated directly with leukocytes and reticulocytes; inversely with lactate dehydrogenase, APACHE, and MODS scores. Areas under ROC curve for platelets, MODS, and APACHE scores to predict survival were 0.73, 0.85, and 0.93, respectively. Conclusions: In severe sickle cell crisis thrombocytopenia is more common than thrombocytosis. In the ICU, day 1 platelet counts correlate inversely with prognostic scores and are significantly reduced in multi-organ failure and nonsurvivors. A platelet count above 175 × 109/L predicts patient survival with high specificity and positive predictive value but lacks sensitivity.

PDF Share
  1. Pakbaz Z, Wun T. Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics. Hematol Oncol Clin North Am 2014;28:355-74.
  2. Kuypers FA. Hemoglobin s polymerization and red cell membrane changes. Hematol Oncol Clin North Am 2014;28:155-79.
  3. Freedman ML, Karpatkin S. Elevated platelet count and megathrombocyte number in sickle cell anemia. Blood 1975;46:579-82.
  4. Okpala I. Steady-state platelet count and complications of sickle cell disease. Hematol J 2002;3:214-5.
  5. Kenny MW, George AJ, Stuart J. Platelet hyperactivity in sickle-cell disease: A consequence of hyposplenism. J Clin Pathol 1980;33:622-5.
  6. Westwick J, Watson-Williams EJ, Krishnamurthi S, Marks G, Ellis V, Scully MF, et al. Platelet activation during steady state sickle cell disease. J Med 1983;14:17-36.
  7. Gordon PA, Breeze GR, Mann JR, Stuart J. Coagulation fibrinolysis in sickle-cell disease. J Clin Pathol 1974;27:485-9.
  8. Alkjaersig N, Fletcher A, Joist H, Chaplin H Jr. Hemostatic alterations accompanying sickle cell pain crises. J Lab Clin Med 1976;88:440-9.
  9. Billett HH, Nagel RL, Fabry ME. Evolution of laboratory parameters during sickle cell painful crisis: Evidence compatible with dense red cell sequestration without thrombosis. Am J Med Sci 1988;296:293-8.
  10. De Franceschi L, Cappellini MD, Olivieri O. Thrombosis and sickle cell disease. Semin Thromb Hemost 2011;37:226-36.
  11. Allen U, MacKinnon H, Zipursky A, Stevens M. Severe thrombocytopenia in sickle cell crisis. Pediatr Hematol Oncol 1988;5:137-41.
  12. Rowley PT, Jacobs M. Hypersplenic thrombocytopenia in sickle cell-bata thalassemia. Am J Med Sci 1972;264:489-93.
  13. Mallouh AA, Salamah MM. Hypersplenism in homozygous sickle-cell disease in Saudi Arabia. Ann Trop Paediatr 1985;5:143-6.
  14. Casey JR, Kinney TR, Ware RE. Acute splenic sequestration in the absence of palpable splenomegaly. Am J Pediatr Hematol Oncol 1994;16:181-2.
  15. Koduri PR. Acute splenic sequestration crisis in adults with sickle cell anemia. Am J Hematol 2007;82:174-5.
  16. Goldstein AR, Anderson MJ, Serjeant GR. Parvovirus associated aplastic crisis in homozygous sickle cell disease. Arch Dis Child 1987;62:585-8.
  17. Hutchinson RM, Merrick MV, White JM. Fat embolism in sickle cell disease. J Clin Pathol 1973;26:620-2.
  18. Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000;342:1855-65.
  19. Ballas SK, Kesen MR, Goldberg MF, Lutty GA, Dampier C, Osunkwo I, et al. Beyond the definitions of the phenotypic complications of sickle cell disease: An update on management. ScientificWorldJournal 2012;2012:949535.
  20. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med 1985;13:818-29.
  21. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ, et al. Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit Care Med 1995;23:1638-52.
  22. Sauaia A, Moore EE, Johnson JL, Ciesla DJ, Biffl WL, Banerjee A, et al. Validation of postinjury multiple organ failure scores. Shock 2009;31:438-47.
  23. Minei JP, Cuschieri J, Sperry J, Moore EE, West MA, Harbrecht BG, et al. The changing pattern and implications of multiple organ failure after blunt injury with hemorrhagic shock. Crit Care Med 2012;40:1129-35.
  24. Chaturvedi S, Ghafuri DL, Glassberg J, Kassim AA, Rodeghier M, DeBaun MR, et al. Rapidly progressive acute chest syndrome in individuals with sickle cell anemia: A distinct acute chest syndrome phenotype. Am J Hematol 2016;91:1185-90.
  25. Gardner K, Thein SL. Super-elevated LDH and thrombocytopenia are markers of a severe subtype of vaso-occlusive crisis in sickle cell disease. Am J Hematol 2015;90:E206-7.
  26. Whelihan MF, Lim MY, Mooberry MJ, Piegore MG, Ilich A, Wogu A, et al. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease. J Thromb Haemost 2016;14:1941-52.
  27. Buseri FI, Jeremiah ZA, Shokunbi WA. Plasma levels of some blood coagulation parameters in Nigerian homozygous sickle cell patients (HbSS) in steady state. Hematology 2006;11:375-9.
  28. Ataga KI, Key NS. Hypercoagulability in sickle cell disease: new approaches to an old problem. ASH Education Program Book. 2007:91-6.
  29. Shome DK, Ramadorai P, Al-Ajmi A, Ali F, Malik N. Thrombotic microangiopathy in sickle cell disease crisis. Ann Hematol 2013;92:509-15.
  30. Alsultan A, Alabdulaali MK, Griffin PJ, Alsuliman AM, Ghabbour HA, Sebastiani P, et al. Sickle cell disease in Saudi Arabia: The phenotype in adults with the Arab-Indian haplotype is not benign. Br J Haematol 2014;164:597-604.
  31. Serjeant GR, Serjeant BE. Sickle Cell Disease. 3rd ed. Oxford: Oxford University Press; 2001. p. 149-69.
  32. Kar BC, Satapathy RK, Kulozik AE, Kulozik M, Sirr S, Serjeant BE, et al. Sickle cell disease in Orissa state, India. Lancet 1986;2:1198-201.
  33. Anea CB, Lyon M, Lee IA, Gonzales JN, Adeyemi A, Falls G, et al. Pulmonary platelet thrombi and vascular pathology in acute chest syndrome in patients with sickle cell disease. Am J Hematol 2016;91:173-8.
  34. Dang NC, Johnson C, Eslami-Farsani M, Haywood LJ. Bone marrow embolism in sickle cell disease: A review. Am J Hematol 2005;79:61-7.
  35. Godeau B, Schaeffer A, Bachir D, Fleury-Feith J, Galacteros F, Verra F, et al. Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: Value for diagnostic assessment of fat embolism. Am J Respir Crit Care Med 1996;153:1691-6.
  36. Gangaraju R, Reddy VV, Marques MB. Fat embolism syndrome secondary to bone marrow necrosis in patients with hemoglobinopathies. South Med J 2016;109:549-53.
  37. Manci EA, Culberson DE, Yang YM, Gardner TM, Powell R, Haynes J Jr., et al. Causes of death in sickle cell disease: An autopsy study. Br J Haematol 2003;123:359-65.
  38. Ataga KI, Orringer EP. Bone marrow necrosis in sickle cell disease: A description of three cases and a review of the literature. Am J Med Sci 2000;320:342-7.
  39. Araneda M, Krishnan V, Hall K, Kalbfleisch J, Krishnaswamy G, Krishnan K. Reactive and clonal thrombocytosis: Proinflammatory and hematopoietic cytokines and acute phase proteins. South Med J 2001;94:417-20.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.